Serum CA 125 and first trimester abortion
- 1 June 1995
- journal article
- research article
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 49 (3), 259-264
- https://doi.org/10.1016/0020-7292(95)02371-i
Abstract
Objective: The study was carried out to assess the clinical value of serum CA 125 in association with serum β-human chorionic gonadotropin (hCG) for predicting pregnancy outcome. Methods: One hundred spontaneous pregnancies, 52 non-threatened pregnancies and 48 with threatened abortions, observed in the Department of Obstetrics and Gynecology at the University ‘La Sapienza’, Rome, Italy, were evaluated during the first trimester using ultrasound examination, CA 125 and β-hCG titrations. Results: Threatened pregnancies had statistically significantly higher CA 125 serum values than non-threatened pregnancies, especially those with a negative outcome (P < 0.01). The CA 125 levels in the threatened pregnancies were positively correlated with the tropho-decidual hematoma volume (r = 0.839, P < 0.0001). The CA 125-β-hCG association showed a higher prognostic value (sensitivity 78.9%, specificity 96.5%) in assessing pregnancy outcome than CA 125 or β-hCG alone (sensitivity 78.9% and 57.9%, respectively; specificity 75.8% and 86.2%, respectively). Conclusions: Our findings are in accordance with the hypothesis of a tropho-decidual origin of this marker, suggesting its possible usefulness in the prognostic evaluation of first trimester threatened abortion.Keywords
This publication has 18 references indexed in Scilit:
- Psychological Stress and Lipoperoxidation in MiscarriageAnnals of the New York Academy of Sciences, 1994
- What do we know about the origin of CA 125?European Journal of Obstetrics & Gynecology and Reproductive Biology, 1993
- Malignant placental site trophoblastic tumor associated with placental abruption, fetal distress, and elevated CA-125Gynecologic Oncology, 1992
- The prognostic significance of maternal serum CA125 measurement in threatened abortionEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1992
- Maternal Serum CA 125 for aneuploidy detection in early pregnancyPrenatal Diagnosis, 1992
- CA 125 is an Excretory Product of Human Endometrial GlandsBiology of Reproduction, 1990
- CA 125 in normal tissues and carcinomas of the uterine cervix, endometrium and fallopian tubeArchiv für Gynäkologie, 1989
- The distribution of CA 125 in the reproductive tract of pregnant and non‐pregnant womenBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Reactivity of a monoclonal antibody with human ovarian carcinoma.JCI Insight, 1981